Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
CCT128930 hydrochloride
Cat. No.:
OB0125LY-100
Appearance:
Solid
Purity:
98.5%
Identity:
Confirmed by NMR and HPLC.
Size:
Product Overview
Description:
CCT128930 hydrochloride is a new small molecule inhibitor that primarily targets the mTOR signaling pathway.
Synonym:
2453324-32-6; 4-(4-Chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-amine hydrochloride; 4-(4-Chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-aminehydrochloride; 4-[ (4-Chlorophenyl)methyl]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-amine;hydrochloride; 4-[ (4-Chlorophenyl)methyl]-1-{7H-pyrrolo[2,3-d]pyrimidin-4-yl}piperidin-4-amine hydrochloride
CAS No.:
2453324-32-6
Compound CID:
146013807
Formula:
C18H21Cl2N5
Formula Weight:
378.3
Specification
Targets & IC50:
PKA: 168 nM; p70 S6K: 120 nM; Akt2: 6 nM
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
CCT128930 hydrochloride can be used to study the regulatory mechanisms of cell proliferation and growth and to explore the role of mTOR in various diseases.
Library Information
Targets:
PKA; Akt; mTOR; Apoptosis; Autophagy
Receptors:
Akt2; Apoptosis; Autophagy; p70S6K; PKA
Pathways:
Autophagy; Apoptosis; Cytoskeletal signaling; PI3K/Akt/mTOR signaling; Tyrosine kinase/adaptors
Plate Number:
AOCL-7
Plate Location:
h2
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
55 mg/mL; 145.39 mM
